Quarterly Report III 16/17
September 2016 – May 2017, Diamyd Medical AB (publ), Fiscal year 2016/2017Reporting period, March 1, 2017 – May 31, 2017 · Net result amounted to MSEK -8.3 (-18.2) · Net result per share amounted to SEK -0.3 (-0.8) · Cash flow from operating activities amounted to MSEK -5.4(-4.3) · Liquid assets and short term investments amounted at the end of the period to MSEK 12.2 (36.5) Nine months, September 1, 2016 – May 31, 2017 · Net result amounted to MSEK -19.0 (-27.2) · Net result per share amounted to SEK -0.6 (-1.0) · Cash flow from operating activities amounted to
